BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
तुलना करने के लिए मीट्रिक्स | BSEM | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBSEMपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 5.4x | 13.6x | −0.6x | |
PEG अनुपात | 1.28 | 0.33 | 0.00 | |
क़ीमत/बुक | 2.2x | 2.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 0.4x | 1.2x | 3.4x | |
अपसाइड (विश्लेषक लक्ष्य) | 290.1% | 115.2% | 41.7% | |
उचित मूल्य अपसाइड | अनलॉक करें | 20.9% | 5.0% | अनलॉक करें |